bioMérieux Initiates Test Card Recall After Customer Complaint
This article was originally published in The Gray Sheet
Executive Summary
bioMérieux estimates that 94 clinical laboratory customers are affected by the recall of its Vitek GPS-107 gram positive susceptibility card (lot M58X)
You may also be interested in...
bioMérieux recall redux
Firm's April 20 recall of Vitek GPS-107 gram positive sensibility cards (lot B28E) is deemed Class I by FDA in 1May 6 letter. bioMérieux received a similar agency communication March 19 regarding the January recall of a separate GPS-107 lot. The recalled cards - used with the automated Vitek for antibiotic susceptibility testing - could report results as if they were GPS-105 cards, which contain ampicillin, levofloxacin and amoxicillin. The first recalled lot affected an estimated 95 clinical laboratory customers (2"The Gray Sheet" March 29, 2004, p. 11)...
Aldeyra Hopes To Refile Dry Eye Drug Reproxalap Later In 2024
Following an FDA complete response letter last November, Aldeyra has agreed with the agency on a trial design to demonstrate efficacy in ocular discomfort, which the company can complete this year.